Regional blood-brain glucose transfer was studied in pentobarbitone-anaesthetized rats using a pro grammed intravenous infusion technique that maintained steady levels of unlabeled (up to 55 mM) and tracer n-glucose in the circulating plasma. Regional cerebral blood flow, glucose phosphorylation rate, and tissue glu cose content were also measured under comparable con ditions. Data were analysed in terms of irreversible Mi chaelis -Menten kinetics assuming independent influx and efflux (Type I) and reversible Michaelis-Menten ki netics (Type II) across both the luminal and the abluminal membranes of the endothelial cell. The latter analysis corresponds to simple stereospecific membrane pores. The mathematical model allowed for changes in tissue glucose content and back-diffusion of tracer during the Glucose is transported across the blood-brain barrier principally by a process of facilitated diffu sion (Crone, 1965; Lund-Andersen, 1979) .
Summary: Regional blood-brain glucose transfer was studied in pentobarbitone-anaesthetized rats using a pro grammed intravenous infusion technique that maintained steady levels of unlabeled (up to 55 mM) and tracer n-glucose in the circulating plasma. Regional cerebral blood flow, glucose phosphorylation rate, and tissue glu cose content were also measured under comparable con ditions. Data were analysed in terms of irreversible Mi chaelis -Menten kinetics assuming independent influx and efflux (Type I) and reversible Michaelis-Menten ki netics (Type II) across both the luminal and the abluminal membranes of the endothelial cell. The latter analysis corresponds to simple stereospecific membrane pores. The mathematical model allowed for changes in tissue glucose content and back-diffusion of tracer during the Glucose is transported across the blood-brain barrier principally by a process of facilitated diffu sion (Crone, 1965; Lund-Andersen, 1979 ). This has been most commonly analysed in terms of irrevers ible Michaelis-Menten equations for both influx and efflux, such that where l i n and l out are the apparent rates of unidi rectional influx and efflux, respectively, for glucose at mean concentrations C p in the capillary plasma and C T in the brain interstitial fluid. T max is the maximal transport capacity, which is usually as sumed to be the same for influx as for efflux, and Kt is the transport constant.
experiments. Type I analyses gave Kt values of �6. 6 mM, whereas those by Type II were consistently lower. Inter regional differences were not significant using either scheme. Comparison of Type II with Type I analyses re vealed a possible explanation for discrepancies in the es timates of non saturable glucose transfer by different methods and highlighted the importance of tissue glucose measurements in studies of unidirectional glucose influx. Since the experimental data may be described equally well by either scheme and some interaction between in flux and efflux across the endothelial cell might be ex pected, consideration of this alternative approach is sug gested. Key Words: Blood-brain barrier-Blood-brain glucose transfer-Double-membrane kinetics-Pro grammed infusion.
The barrier comprises the luminal and abluminal membranes of the capillary endothelial cell (Brad bury, 1979) . If transport across each of these indi vidual membranes is the same and is characterized by expressions equivalent to those above but in volving in addition the concentration of glucose in the endothelial cell, then it may be shown that the expressions for the apparent unidirectional flux across the barrier as a whole are of the same alge braic form as above but that the apparent T max is simply half the maximal transport capacity for each individual membrane of the endothelial cell (Pap penheimer and Setchell, 1973) . This will subse quently be referred to as Type I kinetics.
It has been suggested, however, that an alterna tive saturable kinetic formulation may be more ap propriate (Cunningham, 1986) . This assumes re versible Michaelis-Menten kinetics across each membrane of the endothelial cell and is kinetically equivalent to simple stereospecific pores (Lieb and Stein, 1974 ) equally accessible to glucose on either side of the membrane. Expressions for unidirec-tional fluxes across individual membranes are then of the form (see Appendix)
where 1 X y is the unidirectional flux from X to Y, with X and Y representing either the capillary plasma or the endothelial cytoplasm or the tissue interstitium, with C denoting concentration, and where T s is the single-membrane maximal transport capacity. Such expressions may be combined, as will be described later, to give apparent unidirec tional and net fluxes across the barrier as a whole in terms of mean capillary plasma and tissue glucose concentrations, Cp and CT, and of the kinetic con stants T s and K t . This will subsequently be referred to as Type II kinetics.
The reasons for adopting this alternative ap proach are twofold. First, it is reasonable to sup pose that if influx and efflux occur on the same transport system, then occupancy of the system by influxing glucose should affect its availability for effluxing glucose and vice versa. Type II kinetics represent the simplest such interaction. Second, as will be seen later, the differences between Type I and Type II kinetics may account in part for the so-called nonsaturable component of transport across the barrier, a phenomenon that is method dependent. In this article data on glucose influx in vivo in the anaesthetized rat brain have been ana lysed in terms of both schemes and regional esti mates of the kinetic constants are given in each case. The data were obtained using a programmed step infusion technique for unlabeled and labeled glucose. Since independent data on the regional rates of glucose utilization, blood flow, and glucose content were also available from supplementary experiments on rats in the same state, a compre hensive treatment of data that took into account backflux of tracer was possible. A preliminary ac count of some of this work has been given (Cun ningham et al., 1985) . 
METHODS

Materials
Experimental procedures
Male Sprague-Dawley rats had food withdrawn over night prior to experiment and were anaesthetized with 40 J Cereb Blood Flow Metab. Vol. 6, No.3, 1986 mg/kg i.p. pentobarbitone sodium. Blood gases and pH, heart rate, mean arterial blood pressure, body weight, and temperature typical of these animals are shown in Ta ble 1.
Blood-brain glucose transfer. The flux of glucose from blood to brain was measured using similar tech niques to those of Daniel et al. (1978) . Following induc tion of anaesthesia, cannulae were implanted into one or both femoral veins for programmed infusion of n-glucose and into a femoral artery for blood sampling. Brain up take of glucose was determined using an infusion of p4C]n-glucose programmed to raise rapidly and maintain a concentration of tracer steady in the circulation. After 40-45 s the programmed infusion was stopped, the jug ular veins cut, and the blood flushed out of the cerebral vessels by a retrograde injection of saline through the ar terial cannula (Daniel et aI., 1974) . The rat was decapi tated and the brain rapidly removed and frozen in n hexane cooled to -78°C with solid CO 2 , Tissue samples were stored at -20°C. In some experiments plasma glu cose concentrations were raised artificially to various steady levels, up to 55 mM, by a programmed infusion of unlabeled n-glucose into the contralateral vein. This infu sion started 1 min before and continued throughout the infusion of tracer. The brain tissue was dissected in a cryostat into discrete regions. The left cerebral hemi sphere was taken intact and the right sliced into sections from which were taken samples of cortex, thalamus, cau date-putamen, and hippocampus by reference to the atlas of Pellegrino et al. (1979) . Samples were also taken of cerebellum and brainstem.
Small samples of blood were taken into heparinized sy ringes at intervals during the infusion schedule and imme diately centrifuged. Plasma samples were either diluted in 0.33 M perchloric acid and kept at 4°C before measuring glucose concentration by the hexokinase method or placed in counting vials containing tissue solubilizer. Brain tissue samples were placed in tared counting vials containing solubilizer, weighed, sealed, and left to dis solve before assay of radioactivity. CBF. Regional CBF was determined essentially as de scribed by Ohno et al. (1979) . Single-drop fractions of blood were collected continuously from the femoral ar tery during a constant-rate intravenous infusion of 4-[125Iliodoantipyrine. The animals were killed by decapi tation 25 s after the start of the infusion and fresh brain samples were taken as described previously. Blood and brain samples were immediately sealed in polypropylene vials and counted. Corrections were made to account for radioactivity contained within residual blood in the tissues. The steady-state brain tissue-to-blood partition coefficient for iodoantipyrine was taken to be 0.8 (Sa kurada et aI., 1978) . Regional CBF were calculated as de scribed by Cremer et al. (1983) . Values are means ± SEM for a group of 12 animals.
Cerebral glucose phosphorylation. Regional rates of glucose phosphorylation were determined using the dual label 2-deoxyglucose technique of Cunningham and Cremer (1981) . Each animal was given an intravenous in jection of [U-14C]2-deoxyglucose followed 2 min later by [PH]2-deoxyglucose. After a further 3 min, the animal was killed by cerebrally focussed microwave irradiation. Blood samples were taken from the femoral artery for assay of glucose and radioactivity. The brain was re moved and dissected as described above. For each region measurements were made of [14C]_ and [3H]2-deoxyglu cose and 2-deoxyglucose phosphate. Glucose content of the microwave-fixed tissues was assayed fluorimetrically using the hexokinase method. The method of calculation was modified to take into account regional blood flow (paper in preparation).
MODELS AND CALCULATIONS
Transport across the barrier
Let the unidirectional flux from X to Y be de noted by J xy, where X and Y represent either the capillary plasma P or the endothelial cytoplasm E Net uptake of glucose from plasma to brain
On the basis of a single capillary model with neg ligible transit time, and assuming a rapidly mixed tissue compartment, the net rates of uptake of glu cose A J and of labeled glucose A J * from plasma are given by
where C A is the concentration of (parent) glucose in arterial plasma, Q A and Q T are the concentrations of label in arterial plasma and brain tissue, respec tively, and F is the plasma flow rate. A derivation of expressions equivalent to these is given by
Gjedde ( 1 982).
For Type I kinetics, the apparent permeability surface area products for inflow PS in and outflow PS out are given by
The inclusion of an optional non saturable compo nent of flux, represented by the constant Kd, was also investigated in the present work.
For Type II kinetics the corresponding expres sIOns are Use of the above expressions requires that Cp (the mean concentration of glucose in the capillary plasma) be calculated. Since Cp is in turn a function of CA, F, and A J , iteration is required. Equating Cp initially with C A allows an estimate of C v , the venous plasma glucose concentration, from
CE, the PS values, and Ai may then be recalculated and the iteration repeated to the required reproduc ibility. This approach is also suitable for calculating the log mean capillary concentration. For glucose uptake there is little difference in practice between these two means. An alternative approach to the Type I model has been described that avoids the calculation of effective mean capillary glucose con centrations and takes into account the variation of P S with concentration within the capillar:r (Cun ningham, 1985). However, formulation in terms of apparent mean PS values, as in the present treat ment, allows for a more straightforward compar ison of kinetic schemes.
Experimental model
In ls: Plasma profiles of unlabeled glucose (dotted-dashed lines) and tracer glucose (solid lines) during typical programmed infUSion experiments at normal (a) and raised (50 mM) (b) glucose concentrations. In both cases the level of radioactivity in the plasma has been set at 50 x 103 dpm/ml. Lower panels: Resulting changes in tissue concentration of unlabeled glucose (dotted-dashed lines), tracer glucose (dotted lines), radioactivity in metabolic products (dashed lines), and total accumulat � d radioa ? tivity (sond lines) during the experimental period. Diagrams a and b each represent a single experi ment and describe graphically the integration of the differential equation set (see Experimental Model) with respect to experi mental time using data for the cerebral hemisphere,
Data fitting
The above model can be used with either Type I or Type II kinetics to obtain estimates of T s and K t corresponding to each scheme. In both cases the accumulation of label in the tissue (Fig. 1) is a func tion of the parameters T s and K t . Data were ob tained from up to 46 experimental runs in which the concentration of glucose in plasma ranged from 5 to 55 mM. For each brain region in turn, initial esti mates of T s and K t were made and the above equa tion set integrated numerically (Shampine and Gordon, 1975) under conditions corresponding to each run to allow a comparison with total available data for that region. The values of T s and K t were then varied systematically using an optimization routine (Walsh, 1975) to obtain a weighted least mean squares fit for the region. On the assumption of a constant coefficient of error, data were weighted in inverse proportion to the square of their absolute value.
RESULTS
Estimates of the cerebral phosphorylation rate for glucose, blood flow, and tissue glucose content were obtained for several brain regions in anaesthe tized rats ( Table 2) . These values agree closely with previously published results (Hawkins et aI. , 1979; Gjedde and Rasmussen, 1980; Pardridge et aI., 1982) . These data were incorporated in a model (see Methods) that described the way in which label accumulates in brain tissue during programmed in- Mean estimates of regional cerebral plasma !low and glucose phosphor ylation rate were used as constants when solving the differential equation set for the experimental model. Regional tissue glucose content was de termined in microwave-fixed brain (see Methods) and was used to define the initial conditions at the start of the experiments. Mean arterial plasma glucose concentration in these rats was 5.54 mM.
fusions of unlabeled and tracer glucose. The model takes into account the backflux of label from brain to blood and perturbations in tissue glucose content that occur during the infusions (see Fig. 1 ). This latter factor will be discussed below.
The diagrammatic representations of pro grammed infusions in Fig. 1 illustrate the accumu lation of parent and tracer glucose in the tissue.
Data from a series of such runs allowed estimates to be made of the parameters T s , the single-mem brane maximal transport capacity, and K t o the cor responding transport constant, for either Type I or Type II kinetics. Estimates for the regions studied are given in Ta ble 3 together with their corre- Values are means ± SEM based on n data points. RMS is the weighted residual mean square for each fit. Note that for Type I kinetics, Tso the single-membrane maximal transport capacity. equals twice Tmax. the apparent maximal capacity across the barrier as a whole.
sponding standard errors and the weighted residual mean squares for each fit.
For the Type I scheme, estimates of Kt ranged from 5.4 to 9.7 mM. A simple comparison (F test) of the interregional variation in Kt with the vari ances of the estimates was not significant. It is likely, however, that this test is conservative as the error is inflated by interanimal variation. A similar test showed significant (F = 6.5. p < 0.00 I) inter regional variation in T s ' the single-membrane max imal transport capacity, with cortical regions gener ally showing the highest rates. Inclusion of an addi tional nonsaturable component in the Type I scheme (see Methods) did not produce a significant improvement in fit for any of the regions studied.
Under the Type II scheme, estimates of Kt were consistently lower than under the Type I scheme but with similar standard errors ( Table 3 ). The ki netic significance of this will be discussed later. Again, there was significant interregional variation in the single-membrane maximal transport capacity (F = 8.4, p < 0.00 1).
Despite the marked differences in the numerical values of the estimates between the two analyses, it must be emphasized that operationally within each kinetic scheme they describe the data equally well, as can be seen from the residual mean squares. Fits for Type I and Type II analyses are illustrated in Fig. 2a and b , respectively, by plots of observed versus fitted data points for a typical brain region. The manner in which the estimates were obtained, involving several independent variables. does not allow a conventional raw data plot of unidirectional influx against concentration to display these fits. Theoretical plots will, however, be discussed later 
in the context of the distinctions between the two kinetic schemes.
DISCUSSION
Type I kinetics for a double-membrane system such as the blood-brain barrier were originally an alysed by Pappenheimer and Setchell (1973) who pointed out the consequences of treating the system operationally as a single membrane. Essen tially these were that for unidirectional influx the apparent maximal transport capacity across the barrier as a whole T max would equal half the single membrane capacity T s ' but that the apparent trans port constant Kt would be the same as that for the single membranes. This assumes that the two mem branes constituting the barrier are identical and that a molecule of glucose entering the endothelial cell has the same chance of passing into the tissue as returning to the plasma. This assumption is gener ally supported by the reexamination of Type I ki netics across the double-membrane system carried out by Gjedde and Christensen (1984) .
When the present data were analysed in terms of this Type I kinetic scheme, the average value ob tained for Kt was of the order of 6.6 mM. Using the same technique, Daniel et al. (1978) found a Kt value of 10.5 mM for whole brain. The range of re gional Kt values (5.4-9.7 mM) is similar to the spread observed in both conscious and barbiturate anaesthetized rats using the single-pass carotid in jection (BUl) technique (Pardridge et aI., 1982; Braun et aI., 1985) . LaManna and Harik (1985) have recently reported lower Kt values from 4.4 to 5.1 mM using an intraatrial bolus technique. Based
Observed Observed on autoradiographic measurements over a smaller range of plasma glucose concentrations, Gjedde and Diemer (1985) reported a somewhat wider re gional variation in K t values, although again the average value is similar to the present results. Thus, although there appear to be no major dis agreements as regards an approximate average value for K t in Type I schemes, the extent and sig nificance of interregional variation remain uncer tain. In the present work, the interregional varia tion in K t was not statistically significant. The small variations in the apparent K t may reflect slight dif ferences in the membrane microenvironment within different brain regions. For example, variations in the fluidity of the abluminal membranes may influ ence the ease with which the same transport pro teins facilitate transfer of glucose across the barrier (Pardridge, 1983; Hargreaves et a!., 1986) . Alterna tively, this apparent variation might reflect over simplifications in the kinetic scheme, including the assumption that the two membranes have equal transport capacities. Asymmetry in the maximal transport capacities of the two membranes would give rise to differences in both the apparent T max and K t for transport across the membrane as a whole (Gjedde and Christensen, 1984) .
There is now evidence that transport capacity correlates with metabolic demand for glucose both interregionally and between physiological states Hawkins et a!., 1983; Cremer, 1986) . The values for the regional maximal trans port capacities reported here would allow, under normoglycaemic conditions, transport rates of ap proximately twice the corresponding metabolic rates for glucose in anaesthetized rats. It is likely that the interregional variation in T max partly re flects corresponding differences in the capillary surface area available for transport (Cremer et a!., 1983; Hawkins et aI., 1983; Gjedde and Diemer, 1985) . The additional possibility of interregional differences in the density of transporters within the capillary endothelium cannot, however, be ex cluded.
In contrast to some studies (Cremer and Cun ningham, 1979; Pardridge et a!., 1982) employing the BUI technique (Oldendorf, 1971) , the inclusion of an additional nonsaturable component of unidi rectional influx in the Type I scheme did not result in a significant improvement in fit as judged by the residual mean square. For most regions, estimates of the nonsaturable component were not signifi cantly different from zero. It is difficult to account simply for this discrepancy in terms of Type I ki netics. A possible explanation can, however, be forwarded if analyses are made using the Type II kinetic scheme, the critical factor being the effect of tissue glucose concentration on unidirectional influx under the two schemes. Figure 3 shows theoretical plots of the apparent unidirectional influx of glucose from plasma to brain as a function of plasma glucose concentra tion. Whereas with Type I kinetics (Fig. 3a) unidi rectional influx saturates towards a rate corre sponding to half the single-membrane transport maximum in a manner independent of the tissue glucose concentration, with Type II kinetics the shape of the curve is dependent on the tissue glu cose concentration. With the technique used in the present work, the time scale of the experiments was such that it resulted in significant increases in tissue glucose concentration at high plasma glucose concentrations. To approximate these changes in a theoretical plot (Fig. 3b) , the tissue glucose con centration was varied linearly from 2 to 5 mM across the range of plasma glucose concentrations shown. It can be seen that there is little difference between the Type I and Type II curves when such a change in tissue glucose concentration is allowed for (compare Fig. 3a with b ). This similarity ac counts for the equivalence of the fits to the two schemes obtained in the present work when pertur bation of tissue glucose concentration was modeled. However, if the tissue glucose concen tration were to remain constant over the range of plasma glucose concentrations shown, then a dif ference between Type I and Type II curves would become evident (compare Fig. 3a with c) . This dif ference between the curves (Fig. 3d ) is most ap parent at high plasma glucose concentrations. It may be supposed that the latter condition will apply when influx is measured over periods short enough not to perturb the tissue glucose content. Thus, when data on glucose influx are obtained using short-term injection methods such as the BUI tech nique, an increasing flux at high plasma glucose concentrations might be expected. To accommo date this increase in terms of Type I kinetics has previously required the introduction of an addi tional nonsaturable component of influx. Estimates of this component [0.0083 mllmin/g (Cremer and Cunningham, 1979) , 0.007 ml/min/g (Pardridge et a!., 1982) ] are, however, of a similar magnitude to that that would be predicted on the basis of Type II kinetics alone (Fig. 3d) . Differences between the curves arise with the reversible kinetic scheme be cause of the effects of plasma glucose on efflux and tissue glucose on influx.
This accommodation of results obtained with dif ferent techniques supports the assumption of a Type II kinetic scheme and emphasizes the need for Glucose Concentration (mM) Theoretical plots generated using the kinetic constants for the cerebral hemisphere (see Table 3 ) to show the relation ship between unidirectional glucose influx and plasma glucose concentration. Curves were calculated using Type I kinetics (a) and using Type II kinetics (b) in which the tissue glucose concentration was assumed to vary linearly from 2 to 5 mM across the range of plasma glucose concentrations from 5 to 55 mM. Effect of keeping the tissue glucose concentration constant at 2 mM on the curve predicted by Type II kinetics is shown (e), along with the difference between curves b and c (d).
tissue substrate content to be taken into account in any kinetic study of unidirectional influx. Further support for this alternative scheme stems from the observation that the so-called nonsaturable compo nent of glucose transport is stereospecific (Par dridge et aI., 1982), a property that would not be expected if this component of uptake were simple diffusion. With a Type I scheme, this has led to the suggestion of a further high-capacity -low-affinity component for glucose transport (Pard ridge and Oldendorf, 1977; Gjedde, 1981) , but with the Type II scheme it simply appears as a property of a single-component double-membrane system. The schemes also differ with respect to the rela tionship between the rate of unidirectional efflux J Cereb Blood FloH' Metah. Vol. 6. No.3. 1986 and the tissue glucose concentration, but there is no easy direct experimental access to this relation ship. Under the Type II scheme it will be seen that PS out equals PS in , and the distribution volume of a nonmetabolized glucose analogue might therefore be expected to be close to the water volume of brain. Experimental evidence with 3-0-methylglu cose suggests, however, that it is somewhat lower than this (Lund-Andersen, 1979) . This lower distri bution volume can be accounted for in terms of the Type I kinetic scheme (Gjedde, 1982) , where in general PS out > PS in .
It will be seen from Results that when the esti mates of K t from the two schemes are compared on a region-by-region basis, there is an approximately constant difference between them of the order of 5 mM, reflecting the differences in the denominators of the expressions for the PS values for influx. In the case of Type II kinetics, the concentrations of glucose in the endothelial cell compartment and in the tissue are involved in the denominator. This is not the case in Type I kinetics, where the apparent Kt is in consequence higher. It must be emphasized that the value of Kt in the Type II scheme does not ;:: orrespond to the plasma glucose concentration at which unidirectional influx is half the maximal rate. In the Type II scheme, the Kt is equal to the sum of the concentrations on the two sides of a membrane at which half of the specific channels are occupied from either side. A half-maximal unidirectional in flux would require a concentration equal to the sum of the Kt and the concentration on the opposite side.
The present results show that the relationship be tween unidirectional glucose influx and plasma glu cose concentration, particularly within the physio logical range, can be reasonably described by either kinetic scheme, given the appropriate values for the kinetic constants. A distinction between the schemes is, however, apparent when different methodologies are compared, which favours the Type II. So far, the interpretation of blood-brain glucose transport has been dominated by Type I ki netics. Although both schemes are probably over simplifications of the physiological reality, we would conclude from the above discussion, and from the reasonable assumption that influx and ef flux might interact in some way at the level of the endothelial cell, that the alternative Type II scheme should also be considered.
APPENDIX
This appendix outlines the derivation of equa tions used in the Type II kinetic scheme of the main text. They are based on reversible Michaelis Menten kinetics and are equivalent to a simple pore (Lieb and Stein, 1974) . Suitable simplifying as sumptions appropriate to the present application have been made.
Let transport in the steady state across a single membrane be represented by where S x and S y represent substrate on either side of the membrane at concentrations C x and C y and E and ES represent the unoccupied and occupied binding sites, respectively, at concentrations x and (ex), c being the total. Assuming that the system is symmetrical in that the constants for breakdown h and formation! of the complex are the same on either side, then the unidirectional rate of transfer from X to Y , I xv' is given by the rate of formation of the complex from side X times the fraction released to side Y (i .e., Y2):
Cx' (ex) .! I X y = ----' -----
(Al)
Under steady-state conditions, the rate of forma tion of the complex equals its rate of breakdown to each side, 
Now consider the apparent unidirectional flux I across two membranes, say, from the plasma P to the endothelial cell E to the tissue T. Assuming in stantaneous mixing in the endothelial cell, then l in is given by the flux from P to E times the fraction of the total efflux from E that passes to T:
Assuming that T s and Kt are the same for inward and outward movement across each membrane, then substituting P, E, and T as appropriate for X and Yin Eq. A4 gives Eq. A5 the form where m = Kt + CE + Cp and n = Kt + CE + CT' Simplification and substitution then give the form used in the main text:
with a corresponding expression for l ou t.
